We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Primary Anatomical Versus Primary Electrophysiological Approach in Circumferential Pulmonary Vein Ablation (CPVA-PAF)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2007 by University Hospital, Bonn.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00556595
First Posted: November 12, 2007
Last Update Posted: November 12, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital, Bonn
  Purpose
Randomized comparison between 2 techniques of circumferential pulmonary vein ablation in paroxysmal atrial fibrillation: Primary anatomical ablation with secondary closure of possible electrical gaps versus primary electrophysiological ablation at the sites of atrio-venous electrical breakthroughs with secondary circumferential ablation around the pulmonary vein orifice

Condition Intervention
Paroxysmal Atrial Fibrillation Procedure: primary electrophysiological approach Procedure: primary anatomical approach

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Circumferential Pulmonary Vein Ablation in Paroxysmal Atrial Fibrillation: Randomized Comparison Between a Primary Anatomical Versus a Primary Electrophysiological Approach

Resource links provided by NLM:


Further study details as provided by University Hospital, Bonn:

Primary Outcome Measures:
  • Freedom from atrial tachyarrhythmias at 6-months follow-up [ Time Frame: 6 months ]

Secondary Outcome Measures:
  • Comparison of procedural characteristics (duration, fluoroscopy time, ablation time, ablation energy, complications) [ Time Frame: 6 months ]

Estimated Enrollment: 200
Study Start Date: November 2007
Estimated Study Completion Date: December 2008
Arms Assigned Interventions
Experimental: 1
primary electrophysiological approach
Procedure: primary electrophysiological approach
primary ablation of atrio-venous breakthrough sites followed by circumferential ablation around pulmonary vein orifice
Active Comparator: 2
primary anatomical approach
Procedure: primary anatomical approach
primary circumferential ablation around the pulmonary vein orifice followed by ablation of possible conduction gaps

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • paroxysmal atrial fibrillation
  • age over 18 years

Exclusion Criteria:

  • persistent atrial fibrillation
  • reversible cause of atrial fibrillation
  • inability to comply with follow-up
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00556595


Contacts
Contact: Lars M Lickfett, MD *49-228-287-16670 lars.lickfett@ukb.uni-bonn.de

Sponsors and Collaborators
University Hospital, Bonn
Investigators
Principal Investigator: Lars M Lickfett, MD University Hospital Bonn, Department of Cardiology